Review Article
Volume 4 Issue 3 - 2020
Drug Interactions Prevalence: A Review
Faisal Shakeel1* and Muhammad Aamir2
1Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, USA
2Department of Pharmacy, Sarhad University of Science and Information Technology, Peshawar, Pakistan
*Corresponding Author: Faisal Shakeel, Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, USA.
Received: November 26, 2019; Published: February 29, 2020




Abstract

Aim: To study the prevalence of drug interactions in hospital settings and its comparison in various countries of the world by literature survey.

Method: A review was carried out of the articles published between 2003 and 2013. Various search terms with different combinations were used like Drug interactions, Prevalence, Hospital and ICU. 

Results: The percentage of interactions varied greatly between patients admitted in the critical units as compared to the patients admitted in general wards of the hospital from 70 - 73% potential drug interactions being reported in critical care units as compared to general wards having a maximum of upto 50% potential drug interactions. Also, there was seen a slight increase in the percentage of potential drug interactions at the time of discharge of patients from the hospitals as compared to those reported at the time of admission.

Conclusion: Many studies have been conducted on the prevalence of drug interactions with reports varying widely. Also, the incidence of drug interactions seems to be low in countries having advanced health care monitoring systems.

Keywords: Drug Interactions; ICU

References

  1. Janchawee B., et al. “Pharmacoepidemiologic study of potential drug interactions in outpatients of a university hospital in Thailand”. Journal of Clinical Pharmacology and Therapeutics 30.1 (2005): 13-20.
  2. Jorge Juarez Viera Teixeira., et al. “Potential drug-drug interactions in prescriptions to patients over 45 years of age in primary care, southern Brazil”. Plos One 7.10 (2012): e47062.
  3. Ogbru O. “Drug-Food Interactions”. Clinical Trends in Pharmacy Practice 10 (1996): 53-60.
  4. Paul WA., et al. “Clinically Significant Drug Interactions”. American Family Physician 61.6 (2000): 1745-1754.
  5. Tatro DS. “Drug interactions”. In Herifindal ET and Gourley DR, Textbook of Therapeutics, Drug and Disease Management, 7th Edition Lippincott, Philadelphia (2000): 35-49.
  6. Bertoli R., et al. “Assessment of potential drug-drug interactions at hospital discharge”. Swiss Medical Weekly 140 (2010): w13043.
  7. Sajid Bashir., et al. “Comparative assessment of drug interactions in pediatrics at private and public sector hospitals of Sargodha and Faisalabad”. African Journal of Pharmacy and Pharmacology 5.20 (2011): 2238-2246.
  8. Martinbiancho J., et al. “Profile of drug interactions in hospitalized children”. Pharmacy Practice 5.4 (2007): 157-161.
  9. Muhammad Abbasi Nazari and Neda Khanzadeh Moqhadam. “Evaluation of Pharmacokinetic Drug interactions in prescriptions of intensive care unit in a teaching hospital”. Iranian Journal of Pharmaceutical Research 3 (2006): 215-218.
  10. Sierra P., et al. “Potential and real drug interactions in critical care patients”. Revista Española de Anestesiología y Reanimación 44.10 (1997): 383-387.
  11. Nielsen EW and Dybwik K. “Drug interactions in an intensive care unit”. Tidsskrift for den Norske Lægeforening 124.22 (2004): 2907-2908.
  12. Meneses A and Monteiro HS. “Prevalência de interações medicamentosas“droga-droga” potenciais em duas UTIs (pública X privada) de Fortaleza, Brasil”. Revista Brasileira de Terapia Intensiva 12.1 (2000): 4-7.
  13. Dresser GK and Bailey DG. “A basic conceptual and practical overview of interactions with highly prescribed drugs”. Canadian Journal of Clinical Pharmacology 9.4 (2002): 191-198.
  14. Sabin S Egger., et al. “Potential drug-drug interactions in the medications of medical patients at hospital discharge”. European Journal of Clinical Pharmacology 58.11 (2003): 773-778.
  15. Adriano M and Silvia H. “Prevalence of potential drug interactions in patients in an intensive care unit of a university hospital in Brazil”. Clinics 66.1 (2011): 9-15.
  16. Jean A., et al. “Potential drug interactions prevalence in intensive care units”. Revista Brasileira de Terapia Intensiva 20.4 (2008): 349-354.
  17. Giti H and Seyed A. “An investigation of drug interactions in hospital pharmacy prescriptions”. Iranian Journal of Pharmaceutical Research 1.1 (2002): 15-19.
  18. Joice M and Joao C. “A Pharmacoepidemiologic study of drug interactions in a Brazilian teaching hospital”. Clinics 61.6 (2006): 515-520.
  19. Lubinga S and Uwiduhaye E. “Potential drug-drug interactions on in-patient medication prescriptions at Mbarara Regional Referral Hospital (MRRH) in western Uganda: Prevalence, clinical importance and associated factors”. African Health Sciences 11.3 (2011): 499-507.
  20. Magro L., et al. “Identification of severe potential drug-drug interactions using an Italian general practitioner database”. European Journal of Clinical Pharmacology 64.3 (2008): 303-309. 
  21. Gagne J., et al. “Prevalence and predictors of potential drug drug interactions in Regione Emilia-Romagna, Italy”. Journal of Clinical Pharmacy and Therapeutics 33.2 (2008): 141-151.
  22. Priska V., et al. “Prevalence of drug-drug interactions at hospital entry and during hospital stay of patients in internal medicine”. European Journal of Internal Medicine 19.6 (2008): 413-420.
  23. Sepehri G., et al. “Prevalence of potential drug interactions in an Iranian General Hospital”. Indian Journal of Pharmaceutical Sciences 74.1 (2012): 75-79.
  24. Catia M., et al. “Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV cohort study”. Antiviral Therapy 15.3 (2010): 413-423.
  25. Radhakrishnan R., et al. “Highly active antiretroviral therapy induced drug-drug interactions in Indian Human Immunodeficiency virus positive patients”. Journal of Clinical Medicine and Research 3.5 (2011): 60-67.
  26. Yu K., et al. “Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: A retrospective database study”. Clinical Therapeutics 34.8 (2012): 1696-1704.
  27. Wasif M. “Interaction between Gemcitabine and warfarin causing gastrointestinal bleeding in a patient with pancreatic cancer”. The Journal of Applied Research 5.3 (2005): 434-437.
  28. Catherine I., et al. “Clinically important drug-disease interactions and their prevalence in older adults”. Clinical Therapeutics 28.8 (2006): 1133-1143.
  29. David E., et al. “Incidence Of Major Drug Interactions And Associated Adverse Drug Events In A Surgical Intensive Care Unit”. The Internet Journal of Pharmacology 2.1 (2003).
  30. Rhanna E., et al. “Prevalence of drug interactions in intensive care units in Brazil”. Acta Paulista de Enfermagem 26.2 (2013): 150-157.
  31. Rajendar A., et al. “Clinically important potential drug-drug interactions in outpatient settings”. Research in Social and Administrative Pharmacy 3.4 (2007): 426-437.
  32. Cristiano M., et al. “Drug-drug interactions associated with length of stay and cost of hospitalization”. Journal of Pharmacy and Pharmaceutical Sciences 12.3 (2009): 266-272.
  33. Virendra K., et al. “Potential drug interactions in patients admitted to cardiology wards of a south Indian teaching hospital”. Australasian Medical Journal 4.1 (2011): 9-14.
  34. Silvana M., et al. “Prevalence and classification of drug-drug interactions in intensive care patients”. Einstein 5.4 (2007): 347-351.
  35. Joice M and Joao C. “Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital”. Journal of Pharmacy and Pharmaceutical Sciences 9.3 (2006): 427-433.
  36. Joice M., et al. “Prevalence of potential drug-drug interactions in an intensive care unit at a Brazilian hospital”. Latin American Journal of Pharmacy 31.10 (2012): 1469-1475.
  37. Hossien R., et al. “The prevalence of potential drug interactions in intensive care units”. Iranian Journal of Critical Care Nursing 4.4 (2012): 191-196.
Citation: Faisal Shakeel and Muhammad Aamir. “Drug Interactions Prevalence: A Review”. EC Emergency Medicine and Critical Care 4.3 (2020): 01-07.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


October Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the October issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before November 08, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk